d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] A multicenter, open-label, randomized phase II study to evaluate the efficacy of AUY922 vs pemetrexed or docetaxel in NSCLC patients with EGFR mutations who have progressed on prior EGFR TKI treatment [Country] NO [Cancer type] 
Lung cancer
Nordic NECT - Inclusion completed
Cancer type